HC Wainwright Issues Optimistic Outlook for TCRX Earnings
TScan Therapeutics, Inc. (NASDAQ:TCRX – Free Report) – Equities researchers at HC Wainwright increased their Q2 2025 earnings per share estimates for shares of TScan Therapeutics in a note issued to investors on Wednesday, May 7th. HC Wainwright analyst A. Fein now expects that the company will post earnings of ($0.29) per share for the […]
TScan Therapeutics, Inc. (NASDAQ:TCRX – Free Report) – Equities researchers at HC Wainwright increased their Q2 2025 earnings per share estimates for shares of TScan Therapeutics in a note issued to investors on Wednesday, May 7th. HC Wainwright analyst A. Fein now expects that the company will post earnings of ($0.29) per share for the […]
